Emily Dressler to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Emily Dressler has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.072
-
Massarweh S, Romond E, Black EP, Van Meter E, Shelton B, Kadamyan-Melkumian V, Stevens M, Elledge R. A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure. Breast Cancer Res Treat. 2014 Jan; 143(2):325-32.
Score: 0.044
-
Yan LZ, Dressler EV, Adams VR. Association of hypertension and treatment outcomes in advanced stage non-small cell lung cancer patients treated with bevacizumab or non-bevacizumab containing regimens. J Oncol Pharm Pract. 2018 Apr; 24(3):209-217.
Score: 0.027